Bonerge has initiated a 108-person clinical trial focusing on the anti-aging effects of individual ingredients and their combined synergies on skin health. The trial is set to conclude by March 2025, with expectations to provide significant insights into the anti-aging market and the application of Senolytics in skin health and broader anti-aging treatments.
The STOP-Sepsis trial investigates senolytics' potential to slow sepsis progression in elderly individuals, addressing a critical need for novel sepsis treatments.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.